您的位置: 首页 > 农业专利 > 详情页

KOMBINACIJA ROSUVASTATINA INHIBITORA REDUKTAZE HMG-COA S INHIBITOROM FOSFODIESTERAZE-4, KAO ŠTO JE ROFLUMILAST, ROFLUMILAST-N-OKSID, ZA LIJEÄŚENJE PLUĆNIH BOLESTI
专利权人:
TAKEDA GMBH
发明人:
WOLLIN, STEFAN-LUTZ,WOHLSEN, ANDREA,BRAUN, CLEMENS,MARX, DEGENHARD
申请号:
HRP20140073
公开号:
HRP20140073T1
申请日:
2014.01.21
申请国别(地区):
HR
年份:
2014
代理人:
摘要:
The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease, wherein the PDE4 inhibitor is selected from the group consisting of ROFLUMILAST, a pharmaceutically acceptable salt of ROFLUMILAST, ROFLUMILAST-N-oxide and a pharmaceutically acceptable salt of ROFLUMILAST-N-oxide, the HMG-CoA reductase inhibitor is ROSUVASTATIN or a pharmaceutically acceptable salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充